Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 64

Results For "expertise"

1333 News Found

Max CMD Abhay Soi is new president of NATHEALTH
People | April 04, 2024

Max CMD Abhay Soi is new president of NATHEALTH

New leadership team announced at NATHEALTH Annual General Meeting 2024


MTD acquires Ypsomed's pen needle and BGM businesses
Medical Device | April 01, 2024

MTD acquires Ypsomed's pen needle and BGM businesses

This acquisition enables MTD to open new, strategic markets


Tata Elxsi and Dräger collaborate to drive critical care innovation in India
Healthcare | March 28, 2024

Tata Elxsi and Dräger collaborate to drive critical care innovation in India

This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology


lpca Laboratories enters into Technology Transfer Agreement with Omexa Formulary
News | March 28, 2024

lpca Laboratories enters into Technology Transfer Agreement with Omexa Formulary

Under this agreement, lpca will grant to Omexa a non-exclusive right to research, develop, manufacture and market an anti-cancer biosimilar for the global market


IFF to sell Pharma Solutions business to Roquette for US$ 2.85 billion
News | March 21, 2024

IFF to sell Pharma Solutions business to Roquette for US$ 2.85 billion

Pharma Solutions operates 10 research and development and/or production sites globally


dsm-firmenich launches food and beverages pilot plant in US
News | March 21, 2024

dsm-firmenich launches food and beverages pilot plant in US

The pilot plant is focused on scaling up beverage production and will support applications


Elegen launches Enfina DNA enhancement for rapid synthesis of highly complex DNA
Biotech | March 21, 2024

Elegen launches Enfina DNA enhancement for rapid synthesis of highly complex DNA

Elegen is the only DNA manufacturer delivering the unique combination of complexity, length and NGS-verified accuracy within days


Apollo appoints Dr. Madhu Sasidhar as President & CEO, Hospitals Division
People | March 20, 2024

Apollo appoints Dr. Madhu Sasidhar as President & CEO, Hospitals Division

Dr Madhu will oversee Apollo's hospital business and will focus on continuing to deliver the world's best clinical outcomes


AstraZeneca buys biopharmaceutical company Fusion
News | March 20, 2024

AstraZeneca buys biopharmaceutical company Fusion

To accelerate the development of next-generation radioconjugates to treat cancer